|
1
|
Swerdlow SH, Campo E, Pileri SA, Harris
NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz
AD and Jaffe ES: The 2016 revision of the World Health Organization
classification of lymphoid neoplasms. Blood. 127:2375–2390. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Elharroudi T, Ismaili N, Errihani H and
Jalil A: Primary lymphoma of the ovary. J Cancer Res Ther.
4:195–196. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Salam DSDA, Thit EE, Teoh SH, Tan SY, Peh
SC and Cheah SC: C-MYC, BCL2 and BCL6 translocation in B-cell
non-Hodgkin lymphoma cases. J Cancer. 11:190–198. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nasioudis D, Kampaktsis PN, Frey M, Witkin
SS and Holcomb K: Primary lymphoma of the female genital tract: An
analysis of 697 cases. Gynecol Oncol. 145:305–309. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ng SP, Leong CF, Nurismah MI, Shahila T
and Jamil MA: Primary Burkitt lymphoma of the ovary. Med J
Malaysia. 61:363–365. 2006.PubMed/NCBI
|
|
6
|
Crasta JA and Vallikad E: Ovarian
lymphoma. Indian J Med Paediatr Oncol. 30:28–30. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang H, Lui F and Chen Y: A case of
primary ovary non-Hodgkin's malignant lymphoma. Hunan Yi Ke Da Xue
Xue Bao. 23:5161998.(In Chinese). PubMed/NCBI
|
|
8
|
Fox H, Langley FA, Govan AD, Hill AS and
Bennett MH: Malignant lymphoma presenting as an ovarian tumour: A
clinicopathological analysis of 34 cases. Br J Obstet Gynaecol.
95:386–390. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sarina SJ and Song J: A case report and
literature review of ‘double strike’ ovarian diffuse large b-fine.
Gold lymphoma. Chin J PractGynecol Obstet. 38:247–249. 2022.
|
|
10
|
Wei XX, Zhao Q, Li DP and Huang YH: Recent
advances in diagnosis and treatment of double strike lymphoma. J
Exp Hematol. 27:1311–1315. 2019.
|
|
11
|
Li S, Saksena A, Desai P, Xu J, Zuo Z, Lin
P, Tang G, Yin CC, Seegmiller A, Jorgensen JL, et al: Prognostic
impact of history of follicular lymphoma, induction regimen and
stem cell transplant in patients with MYC/BCL2 double hit lymphoma.
Oncotarget. 7:38122–38132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sehn LH and Salles G: Diffuse large B-cell
lymphoma. N Engl J Med. 384:842–858. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhuang Y, Che J, Wu M, Guo Y, Xu Y, Dong X
and Yang H: Altered pathways and targeted therapy in double hit
lymphoma. J Hematol Oncol. 15:262022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
D'Angelo CR, Hanel W, Chen Y, Yu M, Yang
D, Guo L, Karmali R, Burkart M, Ciccosanti C, David K, et al:
Impact of initial chemotherapy regimen on outcomes for patients
with double-expressor lymphoma: A multi-center analysis. Hematol
Oncol. 39:473–482. 2021. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Savage KJ, Johnson NA, Ben-Neriah S,
Connors JM, Sehn LH, Farinha P, Horsman DE and Gascoyne RD: MYC
gene rearrangements are associated with a poor prognosis in diffuse
large B-cell lymphoma patients treated with R-CHOP chemotherapy.
Blood. 114:3533–3537. 2009. View Article : Google Scholar : PubMed/NCBI
|
